|
This report is being submitted to relay additional information and device evaluation.The following sections are being reported: b4: date of this report was updated.G3: date received by manufacturer was updated.G6: type of report was updated.H2: type of follow up was updated.H3: device evaluated by manufacturer was updated.H6: investigation type codes were added: 3331, 4109, 4110 and 4111.H6: investigation findings code was added: 213.H6: investigation conclusions codes were added: 67 and 4310.H10: narrative/data was updated.One (1) imp, tsv, 3.7, 13, mtxf, mg, ha (tsvth13) was returned for investigation.Device was measured with a caliper and matched print specifications.No malfunctions detected that could lead to reported event.Based on the evaluation, device malfunction has not occurred, and the reported event could not be verified.However, there is no existing nonconformance / capa / hhe/d / ie / product hold against the reported device that did or could cause or contribute to the reported event.Monthly post market trending review identified no adverse events or actionable trends for the reported event or device.Zimvie quality management system (qms) has controls in place to ensure the distribution of conforming products.Therefore, based on the available information, the product was within specifications and conforming when it left zimvie.Dhr review for the lot number, 1249331 revealed no deviations nor non-conformances which could have caused or contributed to the reported event.Sterilization record op 120 str2 was reviewed and verified to have passed all sterilization activities with no issues or nonconformities identified.Complaint history review was performed for the reported lot number for similar events and no other complaint was identified.The complaint is not related to the functional performance of the device.The device could not be functionally tested for the reported failure (pain).The reported event could not be recreated.A definitive root cause could not be determined.However, based on the investigation, risk review and ifu, the most likely causes determined from the investigation are clinician error and patient specific issues.No further investigation or immediate capa / hhe/d escalation is required, as the complaint investigation did not confirm the products were nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.
|